Document:

Exhibit 10.9

  

 

AMENDED AND RESTATED SERVICE: AGREEMENT

 

		(1)	TIZIANA LIFE SCIENCES PLC

		(2)	KUNWAR SHAILUBHAI

 

		Dated	11 July 2019

  

     

     

    

  

Contents

 

	SERVICE AGREEMENT	i
	1.	Definitions and interpretation	1
	2.	Appointment	3
	3.	Term	3
	4.	Duties	3
	5.	Director Indemnity and Insurance	4
	6.	Hours of work	4
	7.	Place of Work	4
	8.	Expenses	5
	9.	Salary	5
	10.	Bonus	5
	11.	Pension	6
	12.	Share Option and Long Term Incentive Plan	6
	13.	Other Benefits	6
	14.	Holidays	7
	15.	Sickness Absence	7
	16.	Sick Pay	8
	17.	Obligations during Employment	9
	18.	Confidential Information	10
	19.	Intellectual Property	10
	20.	Garden Leave	11
	21.	Payment in lieu of notice	12
	22.	Summary Termination	13
	23.	Reconstruction and Amalgamation	14
	24.	Obligations after Employment	14
	25.	Property	14
	26.	Resignation from Appointments	14
	27.	Suspension	14
	28.	Disciplinary and Dismissal Rules	15
	29.	Grievance	15
	30.	Data Protection	15
	31.	Warranty	16
	32.	Deductions	16
	33.	Power of Attorney	16
	34.	Collective Agreements	16
	35.	Entire Agreement	16
	36.	Third Parties	16
	37.	Releases and waivers	17
	38.	Notices	17
	39.	Variation	17
	40.	Counterparts	17
	41.	Governing law and jurisdiction	17
	Schedule 1	18
	(Post termination restrictions)	18

 

    ii

     

    

  

This
Agreement is made on                 11
July 2019

 

Between:

  

		(1)	TIZIANA LIFE SCIENCES PLC (company
                                         number: 03508592) whose registered office is at 3rd Floor 11-12 St. James’s Square, London
                                         SW1Y 4LB, United Kingdom (the “Company”); and

 

		(2)	KUNWAR
                                         SHAILUBHAI of 313 Rowland Lane, Line Lexington, PA 18932, USA (“You”).
                                         It is agreed as follows:

 

		1.	Definitions and interpretation

 

		1.1	In this Agreement, unless the context otherwise requires:

 

“Agreement” means this Agreement
(including any schedule or annexure to it).

 

“Board” means
the board of directors of the Company from time to time and includes any committee of the Board duly appointed by it.

 

“Businesses” means the development
of therapeutics and diagnostics for cancers and immune diseases and any trade or other commercial activity which is carried on
by the Company and/or any Group Company, or which the Company and/or any Group Company shall have determined to carry on with
a view to profit in the immediate or foreseeable future. “Commencement Date” means 16 January 2019.

 

“Confidential Information” means
any trade secrets or other information which is confidential, commercially sensitive and is not in the public domain relating
or belonging to the Company and/or any Group Company including but not limited to:

 

		(a)	information relating to the business methods, corporate
plans, management systems, finances, new business opportunities, research and development projects, marketing or sales of any
past, present or future product or service;

 

		(b)	secret formulae, processes, inventions, designs, know-how discoveries, technical specifications
and other technical information relating to the creation, production or supply of any past, present or future product or service
of the Company and/or any Group Company;

 

		(c)	lists or details of customers, potential customers or suppliers or the arrangements made with any
customer or supplier; and

 

		(d)	any information in respect of which the Company and/or any Group Company owes an obligation of
confidentiality to any third party.

 

“Duties” means your duties as referred
to in clause 4.

 

“Employment” means your period
of employment under this Agreement which shall be deemed to include any period of garden leave served under clause 20.

 

“Group Companies”
or “Group” means the Company, Rasna Therapeutics Inc. and any holding company or any parent company or
any subsidiary or subsidiary undertaking of the Company, Rasna Therapeutics Inc. or such companies, as such terms are defined
in s 1159, s 1162 (together with Schedule 7 and the definition of “parent company” in s 1173), s 1161 and Schedule 6
of the Companies Act 2006, and “Group Company” means any of them.

  

     1

     

    

 

“HMRC” means Her Majesty’s Revenue
and Customs.

 

“Holiday Year” means
the period 1 January to 31 December or such other period of one year as the Company may notify to you in writing from time to time.

 

“Invention” means
any know how, technique, process, improvement, invention or discovery (whether patentable or not) which you (whether alone or with
any other person) make, conceive, create, develop, write, devise or acquire at any time during your Employment and which relates
or could relate directly or indirectly to the Businesses.

 

“Material Interest” means:

 

		(a)	the holding of any position (whether employed or engaged)
or the provision of services as director, officer, employee, consultant, adviser, partner, principal, agent or volunteer;

 

		(b)	the direct or indirect control or ownership (whether
jointly or alone) of any shares (or any voting rights attached to them) or debentures save for the ownership for investment purposes
only of not more than 5 per cent of the issued ordinary shares of any company whose shares are listed on any Recognised Exchange;
or

 

		(c)	the direct or indirect provision of any financial assistance.

 

“Model Code” means
the Model Code on directors’ dealings in securities set out in the Listing Rules contained in the FCA handbook, as amended or replaced
from time to time.

 

“Pension Scheme” means the scheme
referred to in clause 11.

 

“Recognised Exchange”
means any of a recognised investment exchange (as defined in s 285 Financial Services and Markets Act 2000 (“FSMA”)),
an overseas investment exchange (as defined in s 313 FSMA), or a relevant market (as defined in article 37 FSMA 2000 (Financial
Promotion) Order 2005.

 

“Schemes” means such schemes
as the Company may operate from time to time, which you are eligible to participate in and which are referred to in clause
13.1.

 

“Termination Date” means the date
on which the Employment terminates.

 

“Works” means
all works including without limitation all copyright works or designs originated, conceived, developed or written by you alone
or with others during the Employment which relate to or could relate to the Businesses.

 

		1.2	In this Agreement, unless the context otherwise requires:

 

		(a)	words in the singular include the plural and vice
versa and words in one gender include any other gender;

 

		(b)	a reference to a statute or statutory provision includes:

 

		(i)	any subordinate legislation (as defined in Section 21(1), Interpretation Act 1978) made under it; and

 

		(ii)	any statute or statutory provision which modifies, consolidates, re-enacts or supersedes it;

  

     2

     

    

  

		(c)	a reference to:

 

		(i)	a
“person” includes any individual, firm, body corporate, association or partnership, government or state (whether
or not having a separate legal personality);

 

		(ii)	clauses and schedules are to clauses and schedules of this Agreement and references to sub-clauses
and paragraphs are references to sub-clauses and paragraphs of the clause or schedule in which they appear; and

 

		(iii)	“indemnify” and “indemnifying” any person against any circumstance
include indemnifying and keeping him harmless from all actions, claims and proceedings from time to time made against him and all
loss or damage and all payments (including fines, penalties and interest, costs or expenses) made or incurred by that person as
a consequence of or which would not have arisen but for that circumstance;

 

		(d)	Except where otherwise stated, words and phrases defined in the City Code on Take- overs and Mergers
or in the Companies Act 2006 have the same meaning in this Agreement.

 

		2.	Appointment

 

The Company appoints you and
you agree to serve as Chief Executive Officer (“CEO”) and Chief Scientific Officer (“CSO”)
of the Company or such other position as the Company may reasonably require from time to time on the terms of this Agreement.

 

		3.	Term

 

		3.1	Your Employment with the Company shall be deemed to have
commenced on the Commencement Date. No previous employment shall count as part of your continuous period of employment nor shall
your prior (and continuing directorship of the Company.

 

		3.2	Subject to the terms of this Agreement, your Employment
shall continue until terminated by either party giving to the other not less than 12 months’ prior written notice.

 

		4.	Duties

 

		4.1	You shall carry out such duties as attach to your office
of Chief Executive Office and Chief Scientific Officer and any other duties for the Company and/or any Group Company which the
Board assigns to you from time to time. It is agreed that your duties shall also extent to as Chief Executive Officer of the Company;
it being agreed that this additional appointment is included in the scope of your duties and compensation and the Board may at
any time either terminate this aspect of your duties at any time, or, with your consent, make such role a permanent part of your
duties, but so that no termination or confirmation shall give rise to any termination or this Agreement either expressly or by
implication and no termination of the role of Chief Executive Officer shall give rise to any right of compensation for loss of
office.

 

		4.2	Without additional remuneration, you shall accept and hold
for such period(s) as specified by the Board, any office(s) including any post(s) as director, trustee, nominee and/or representative
of the Company and/or any Group Company.

 

		4.3	Subject to the terms of this Agreement, you shall:

 

		(a)	devote such of your working time and attention to the Employment
hereunder as may be agreed with the Board from time to time;

 

		(b)	perform the Duties faithfully and diligently and exercise such powers consistent with those Duties
as are assigned to or vested in you by the Company and/or any Group Company and in all cases you shall do so jointly with any person(s)
appointed by the Board from time to time;

 

     3

     

    

  

		(c)	comply
with all common law, fiduciary and statutory duties to the Company and any Group Company, including, but not limited to the seven
statutory duties set out in s 171 - 177 Companies Act 2006, so far as they are in force;

 

		(d)	obey all lawful and reasonable directions of the Board;

 

		(e)	observe in form and spirit such restrictions or limitations
as may from time to time be imposed by the Board;

 

		(f)	implement and observe in form and spirit any relevant Company and/or Group Company policy, procedures,
rules and regulations (whether formal or informal);

 

		(g)	use your best endeavours to foster the Company’s interests and save where this causes a conflict
with the Company’s interests, those of its other Group Companies;

 

		(h)	report to the Board any relevant wrongdoing (including any misconduct or dishonesty) whether committed,
contemplated or discussed by any director, employee or worker of the Company and/or any Group Company of which you are aware and
irrespective of whether this may involve any degree of self-incrimination; and

 

		(i)	keep the Board properly and fully informed in such manner prescribed (with explanations where requested)
of your compliance with the Duties and the affairs of the Company and/or any Group Company.

 

		5.	Director Indemnity and Insurance

 

		5.1	The Company shall indemnify and keep you indemnified from
any liability incurred by you for negligence, default, breach of duty or breach of trust in relation to the affairs of the Company
to the extent permitted by the Companies Act 2006 (as amended) and the Company’s articles of association from time to time. If
the Company’s articles of association are amended at any time to preclude the Company providing this indemnity to you, the Company
shall indemnify and keep you indemnified in respect of any liability incurred by you as a result.

 

		5.2	The Company may also, to the extent permitted by the Companies
Act 2006 (as amended), fund your expenditure on defending proceedings brought under the heads of liability set out in clause 5.1
above.

 

		5.3	The provisions of this indemnity shall survive the termination
of this Agreement howsoever caused, but in relation to each head of liability set out in paragraph 5.1 above, shall automatically
terminate and no longer be of any force or effect upon the expiration of the relevant limitation period for bringing a claim under
that head.

 

		5.4	Directors’ and officers’ liability insurance is provided
for all directors of the Company. The current indemnity limit is £20,000,000. Further details of this insurance can be obtained
from the company secretary.

 

		6.	Hours of work

 

You shall work such hours as may be necessary
for the proper discharge of your Duties. You agree that your employment falls within Regulation 20 of the Working Time
Regulations 1998.

 

		7.	Place of Work

 

		7.1	Your principal place of work shall be at the offices of
the Company’s subsidiary in the United States of America at 3805 Old Easton Road, Doylestown, PA The Company reserves the right
to change your principal place of work on giving reasonable prior notice to you.

 

		7.2	You shall travel to and work on a temporary basis from
such locations within and outside of the United States of America and Europe as the Board may reasonably require. There is no
current requirement for you to work outside the United States of America for any consecutive period of one month or more.

 

     4

     

    

  

		8.	Expenses

 

		8.1	The Company will reimburse to you (or as the case may be
procure the reimbursement of) all expenses wholly, properly and necessarily incurred by you in the performance of the Duties subject
to production within 30 days of the expense being incurred of such receipts or other evidence of expenditure as the Company may
reasonably require and in accordance with the Company’s policy on expenses in force from time to time.

 

		8.2	If you are provided with any credit or charge card by the
Company, you must take good care of it and use it solely for expenses incurred by you in carrying out the Duties and in accordance
with any applicable Company policy. The loss of any such card must be reported immediately to the Company and it must be returned
to the Company immediately upon request.

 

		9.	Salary

 

		9.1	You will be paid a salary of $600,000 per annum (on the
basis that your Duties will involve working hours of 100% of a full-time position but otherwise subject to adjustment to be agreed
with the Board), subject to deduction of such tax and national insurance and/or social security contributions as the Company is
required by law to deduct and which is inclusive of any fees you are entitled to as a director of the Company and/or any Group
Company.

 

		9.2	Your salary will accrue from day to day and is payable
in equal monthly instalments of $50,000 in arrears on or about the last working day of each month, directly into a bank or building
society account nominated by you.

 

		9.3	Your salary will be reviewed by the Board on or about 28
February each year, save where you are working under notice of termination. There is no obligation on the Board to increase your
salary. Any increase awarded will be effective from the date specified
by the Board.

 

		9.4	The Company may, in its absolute
discretion, pay additional remuneration to you, whether by way of bonus or otherwise. Any such payment shall not form part of your
salary for the purposes of this clause 9.

 

		10.	Bonus

 

		10.1	The Company may award you a bonus of such amount and subject
to such conditions (including, but not limited to, conditions for and timing of payment, subject to clause 10.5) as the Board
may in its absolute discretion determine from time to time. It is expected that that bonus eligibility will be equal to 35% of
the salary figure set out in clause 9.1. The Board reserves the right to award a nil bonus.

 

		10.2	Any bonus awarded to you shall be purely discretionary,
shall not form part of your contractual remuneration under this Agreement and shall not be pensionable. The making of an award
shall not oblige the Company to make any subsequent bonus awards.

 

		10.3	Notwithstanding clause 10.1, you shall have no right to
be awarded or where an award has been made, paid a bonus (pro rata or otherwise) if:

 

		(a)	you are subject to any capability and/or disciplinary procedures;
and/or

 

		(b)	your employment has terminated (whether lawfully or unlawfully)
or you are under notice of termination (whether given by you or the Company).

 

		10.4	If you have been notified that you are under investigation
in accordance with our disciplinary or capability procedure then your eligibility to be considered for a discretionary bonus will
be postponed pending the conclusion of any such investigation and any subsequent disciplinary hearing or capability meeting.

 

     5

     

    

  

		10.5	Any earned bonus will be paid in accordance with the Company’s
bonus payment practices in effect from time to time for senior executives of the Company, but no later than March 15 of the calendar
year immediately following the calendar year for which the bonus is being measured. The bonus will be subject to such conditions
(including, but not limited to, conditions based on

 

		10.6	your performance and that of the Company and conditions
relating to the timing of payment) as the Company may in its absolute discretion determine from time to time. The Company reserves
the right to award a nil payment and the making of an award shall not oblige the Company to make any subsequent awards. You shall
have no right to be awarded or where an award has been made, paid any bonus (pro rata or otherwise) if your employment has terminated.

 

		11.	Pension

 

		11.1	The Company will comply with the employer pension duties
in accordance with part 1 of the Pensions Act 2008.

 

		11.2	A contracting out certificate is not in force in respect
of the Employment.

 

		12.	Share Option
                                         and Long Term Incentive Plan

 

		12.1	The terms of the Employment shall not be affected in any
way by your participation or entitlement to participate in any long term incentive plan or share option scheme. Such schemes and/or
plans shall not form part of the terms of the Employment ( express or implied).

 

		12.2	In calculating any payment, compensation or damages on
the termination of the Employment for whatever reason (whether lawful or unlawful) which might otherwise be payable to you, no
account shall be taken of your participation in any such schemes and/or plans referred to in clause 12.1 or any impact upon participation
such termination may have.

 

		13.	Other Benefits

 

		13.1	Subject to clauses 13.2 to 13.7 below, you shall be entitled
to participate in such benefit schemes as the Company may operate from time to time and in which you are eligible to participate
including:

 

		(a)	the permanent health insurance scheme;

 

		(b)	the life assurance scheme; and

 

		(c)	the private medical expenses insurance scheme.

 

		13.2	The Company will agree with you as regards how participation
is shared between the Company’s Schemes and those of Rasna Therapeutics Inc.

 

		13.3	Participation and entitlement to benefits under any of
the Schemes is subject to:

 

		(a)	the terms of the relevant Scheme as amended from time to
time;

 

		(b)	the rules or policies as amended from time to time of the relevant Scheme provider;

 

		(c)	acceptance by the relevant Scheme provider; and

 

		(d)	satisfaction of the normal underwriting requirements of the relevant Scheme provider and the premium
being at a rate which the Company considers reasonable.

 

     6

     

    

  

		13.4	The Company shall only be obliged to make any payment under
any Scheme where it has received payment from the relevant Scheme provider for that purpose. If a Scheme provider refuses to provide
any benefit to you, whether based on its own interpretation of the terms and/or rules of the relevant Scheme or otherwise, the
Company shall not be liable to provide  you with any replacement benefit whatsoever or pay any compensation in lieu of
such benefit.

 

		13.5	The Company, in its absolute discretion, reserves the right
to discontinue, vary or amend any of the Schemes (including the provider and/or level of cover provided under any Scheme) at any
time on reasonable notice to you.

 

		13.6	Any other benefit provided to you shall, unless otherwise
agreed in writing, be at the absolute discretion of the Company who may, at any time, withdraw or vary the terms of any such benefit
as it sees fit.

 

		13.7	You agree that the Company shall be under no obligation
to continue this Agreement and the Employment so that you continue to receive benefits under this Agreement. In particular, you
agree that the Company may terminate the Employment notwithstanding any rights which you may have to participate in and/or obtain
benefits under any permanent health insurance scheme which the Company operates from time to time. You agree that you shall have
no entitlement to compensation or otherwise from the Company and/or any Group Company for the loss of any such entitlements and/or
benefits.

 

		14.	Holidays

 

		14.1	In addition to the usual public or bank holidays in England
and Wales, you are entitled to 20 working days’ paid holiday in each Holiday Year (pro rated to the nearest half day for the Holiday
Year in which the Employment commences and terminates) and pro rated according to the scope of your hours as compared to a full
time employee.

 

		14.2	Holiday must be taken at such times as are agreed with
the Board. On giving at least 5 days’ notice, the Company may require you to take any accrued but untaken holiday where you are
under notice of termination (including where you are on garden leave pursuant to clause 20).

 

		14.3	You may carry forward 5 working days’ holiday to the next
Holiday Year with the consent of the Board and provided that such holiday is used by 31 March in the next Holiday Year. Save as
provided for in clause 14.4 no payment in lieu will be made of any unused holiday entitlement in any Holiday Year.

 

		14.4	On termination of the Employment:

 

		(a)	you will be entitled to pay in lieu of any accrued
but untaken holiday entitlement; or

 

		(b)	you will be required to repay to the Company any salary received for holiday taken in excess of
your accrued entitlement (which you agree may be deducted from any payments, including salary, due to you from the Company).

 

Any payment or repayment pursuant
to this clause will be calculated on the basis of 1/260 of your salary payable pursuant to clause 9 for each day of holiday. It
will not be calculated on any entitlement to bonus, commission, allowance or other payment.

 

		15.	Sickness Absence

 

		15.1	If you are unable to perform the Duties due to sickness
or injury, you must comply with the Company’s sickness policy from time to time in force.

 

		15.2	If at any time in the reasonable opinion of the Board you
are unable to perform all or part of the Duties, you will at the request and expense of the Company:

 

		(a)	consent to an examination by a doctor nominated by the
Company; and

 

		(b)	authorise
the doctor to disclose to and discuss with the Company, his or her report (including copies) of the examination and your fitness
for work.

 

     7

     

    

  

		15.3	The Company is entitled to rely on the reasonable opinion
of any doctor engaged to examine you under clause 15.2 as to your fitness for work. Where such doctor considers you to be unfit
for work, you are not entitled to receive any payment in excess of any sick pay entitlement pursuant to clause 16.

 

		16.	Sick Pay

 

		16.1	Subject to compliance with clause 15 and clauses 16.2 and
16.5 below, you will be entitled to your salary (pursuant to clause 9.1) and, subject to the rules of any applicable scheme, any
contractual benefits for a total of 45 days absence in any period of 12 consecutive months and after that such remuneration or
benefits (if any) as the Board may in its absolute discretion determine from time to time. Any payment made to you under this
clause is inclusive of your entitlement (if any) to statutory sick pay or any pay required under applicable United States federal,
state, or local law (in either case. for which your qualifying days are Monday to Friday).

 

		16.2	Where your absence(s) exceed(s) 45 days in any period of
12 consecutive months, you shall have no entitlement to any remuneration or benefits pursuant to clause 16.1 (whether or not the
Board has exercised its discretion to provide any additional remuneration or benefits for any absence(s) in excess of the 45 days
referred to in that clause) until you have returned to work and remained at work for a continuous period of 13 weeks, unless required
by applicable United States federal, state, or local law.

 

		16.3	At the absolute discretion of the Company no sick pay,
except for any statutory sick pay or any pay required under applicable United States federal, state, or local law, will be payable
in respect of any period where:

 

		(a)	any hearing is pending which relates to any aspect of your
conduct or performance or redundancy and which could result in the imposition of a warning, dismissal or other sanction (including
any performance measure); or

 

		(b)	you refuse to consent to:

 

		(i)	a medical examination at any time by a doctor appointed
by the Company; and/or

 

		(ii)	the provision of your medical records to that doctor; and/or

 

		(iii)	the results of such examination being disclosed to the Company and the Company discussing such
results with the relevant where the examination is germane to your ability to perform the Duties.

 

		(c)	You refuse upon request:

 

		(i)	to obtain a medical certification from your GP or another
person responsible for your clinical care; and/or

 

		(ii)	to provide this certification to the Company.

 

		16.4	For the purpose of clauses 16.1 and 16.3, any delay by
the Company in terminating the provision of sick pay and/or any other remuneration and/or benefits will not constitute a waiver
of its right to do so.

 

     8

     

    

  

		16.5	If your sickness or injury is or appears to be caused by
the negligence, nuisance or breach of any statutory duty of a third party, in respect of which damages are or may be recoverable
you shall:

 

		(a)	immediately
notify the Board of all relevant facts and of any claim, compromise, settlement or judgement made or awarded in connection with
it and all relevant particulars that the Board may reasonably require; and

 

		(b)	if required by the Board, refund to the Company that part of any damages or compensation recovered
by you relating to your loss of earnings for the period of sickness or injury as the Board reasonably determines provided that
the amount to be refunded shall not exceed the total amount paid to you by the Company in respect of the period of sickness or
injury.

 

		16.6	This clause 16 is without prejudice and does not limit
in anyway the Company’s right to terminate your employment pursuant to this Agreement.

 

		16.7	This clause 16 shall be interpreted and applied consistent
with all applicable laws, including but not limited to the Americans with Disabilities Act and the Family and Medical Leave Act
(if applicable).

 

		17.	Obligations during Employment

 

		17.1	Save with the prior written permission of the Board, you
shall not during your employment (whether during or outside normal working hours):

 

		(a)	hold any Material Interest in any person which:

 

		(i)	is or shall be wholly or partly in competition with any
of the Businesses;

 

		(ii)	impairs or might reasonably be thought by the Company to impair your ability to act at all times
in the best interests of the Company and/or any Group Company; and/or

 

		(iii)	requires or might reasonably be thought by the Company to require you to make use of or disclose
any Confidential Information to further your interests in that person;

 

		(b)	take any preparatory steps to become engaged or interested
in any capacity whatsoever in any business or venture which is in or is intended to enter into competition with any of the Businesses;

 

		(c)	carry out any public or private work other than the Duties
(whether for profit or otherwise);

 

		(d)	directly or indirectly receive in respect of any goods
or services sold or purchased or any other business transacted (whether or not by you) by or on behalf of the Company and/or any
Group Company any discount, rebate, commission or other inducement (whether in cash or in kind) which is not authorised by the
relevant Company and/or Group Company rules or guidelines. You will account to the Company for the value of any such inducement,

 

provided that it is expressly agreed that you may
continue to consult to Synergy Pharmaceuticals Inc.

 

		17.2	You shall observe relevant rules of law, requirements,
recommendations, rules and regulations (as amended from time to time) of the London Stock Exchange pie or any other Recognised
Exchange, the Model Code and/or the FSMA and the Company guidelines/codes relating to dealings in shares, debentures or other
securities of the Company and/or any Group Company. In relation to overseas dealing you shall observe all laws and all regulations
of the stock exchange, market or dealing system in which country or state such dealings take place.

 

     9

     

    

  

		18.	Confidential
                                         Information

 

		18.1	You shall not either during the Employment or at any time
after its termination (howsoever arising), directly or indirectly, use, disclose or communicate to any person whatsoever, and
shall use your best endeavours to prevent the publication or disclosure of, any Confidential Information.

 

		18.2	Clause 18.1 does not apply to:

 

		(a)	any use or disclosure in the proper performance of the Duties, as authorised by the Board and/or
as required by law;

 

		(b)	any information which is already in or comes into the public domain other than through your unauthorised
disclosure; and/or

 

		(c)	any protected disclosure within the meaning of s43A Employment Rights Act 1996 provided, where
at the relevant time you are employed by the Company, you have fully complied with the Company’s procedures relating to such disclosures.

 

		19.	Intellectual Property

 

		19.1	You shall promptly disclose to the Company full details
of any Invention and/or Works (including, without limitation, any and all computer programs, photographs, plans, records, drawings
and models) which you (whether alone or with any other person) make, conceive, create, develop, write, devise or acquire at any
time during the Employment and which relates or could relate directly or indirectly to the Businesses. You shall treat all Inventions
and Works as Confidential Information of the Company and/or any Group Company.

 

		19.2	To the extent not already vested in the Company and/or
any Group Company by operation of law, you:

 

		(a)	shall hold any Invention and/or Work on trust for the Company and/or any Group Company until any
rights to such Invention and/or Work have been fully and absolutely vested in the Company in accordance with the remaining provisions
of this clause 19;

 

		(b)	shall subject to clauses 39-43 of the Patents Act 1977 assign to the Company all patents and rights
to apply for patents or other appropriate forms of protection in each Invention throughout the world;

 

		(c)	hereby assign by way of present and future assignment all copyright, design rights and other proprietary
intellectual property rights (if any) for their full terms throughout the world in respect of the Works.

 

		(d)	shall execute any document necessary to assign to the Company any rights referred to under this
clause 19 and at the request and expense of the Company, do all things necessary or desirable (including entering into any agreement
that the Company reasonably requires) to vest such rights in the Company including without limitation applying and joining in with
the Company in applying for any protection for or registration of any such rights to enable the Company and/or any Group Company
and/or its or their nominee to obtain the full benefit and/or substantiate the rights of the Company and/or any Group Company under
paragraphs (a), (b) and (c).

 

		19.3	You acknowledge and agree that the patenting and exploitation
of any Invention shall be at the sole discretion of the Company.

 

		19.4	You irrevocably and unconditionally waive in favour of
the Company and/or any Group Company any and all moral rights conferred on you by Chapter IV, Part I, Copyright Designs and Patents
Act 1988 and any other moral rights provided for under the laws now or in future in force in any part of the world for any Work
the rights in which are vested in the Company whether by clause 19.2 or otherwise.

 

     10

     

    

 

		19.5	You
irrevocably appoint the Company to be your attorney in your name and on your behalf to execute documents, use your name and do
all things which are necessary or desirable for the Company to obtain for itself or its nominee the full benefit of this clause.
A certificate in writing, signed by any director or the secretary of the Company, that any instrument or act falls within the
authority conferred by this Agreement shall be conclusive evidence that such is the case so far as any third party is concerned.

 

		20.	Garden
Leave

 

		20.1	During
any period of notice to terminate the Employment (whether given by you or the Company), or if you purport to terminate the Employment
in breach of this Agreement, the Board may for all or part of that period, in its absolute discretion (and notwithstanding any
other provisions of this Agreement) require you:

 

		(a)	to
perform only such of the Duties as it may allocate to you or such other projects or duties as may be required (whether or not
they fall within clause 4);

 

		(b)	not
to perform any of the Duties;

 

		(c)	not
to have any contact (other than purely social contact) or deal with (or attempt to contact or deal with) any officer, employee,
consultant, client, customer, supplier, agent, distributor, shareholder, adviser or other business contact of the Company and/or
any Group Company save as determined by the Board;

 

		(d)	to
disclose to the Board any attempted contact (other than purely social contact) with any person with whom you have been required
not to have any contact pursuant to this clause;

 

		(e)	to
take any accrued holiday entitlement (in accordance with clause 14.2);

 

		(f)	not
to enter any premises of the Company and/or any Group Company nor to visit the premises of any suppliers and/or customers of the
Company and/or any Group Company;

 

		(g)	to
return as requested by the Board any mobile telephone handset, SIM card, laptop computer and/or any other Company and/or Group
Company property, including Confidential Information, the Board may require; and/or

 

		(h)	to
resign immediately from any offices you hold in the Company and/or any Group Company.

 

		20.2	You
agree that any action taken on the part of the Company and/or any Group Company pursuant to clause 20.1 shall not constitute a
breach of this Agreement of any kind whatsoever nor will you have any claim against the Company and/or any Group Company in respect
of such action.

 

		20.3	Without
prejudice to any other terms of this Agreement and save as expressly agreed otherwise in clause 20.1 above, during any period
in which action is taken on the part of the Company and/or any Group Company pursuant to clause 20.1:

 

		(a)	you
shall continue to be entitled to your salary and contractual benefits save that, should you work for any other person or on your
own account and fail to be available for work at any time, your right to salary and contractual benefits in respect of such period
of non-availability shall be forfeit, notwithstanding any other provision of this Agreement;

  

     11

     

    

 

		(b)	you
                                         shall owe a duty of utmost good faith to the Company and/or any Group Company; and

 

		(c)	you
                                         shall remain an employee of the Company and be bound by the terms and conditions of this
                                         Agreement. In particular, you agree that you will not work for any other person or on
                                         your own account and save, during any periods of holiday taken under this Agreement,
                                         you shall remain readily contactable and available to work for the Company and/or any
                                         Group Company.

 

		21.	Payment
in lieu of notice

 

		21.1	The
Company may in its absolute discretion, terminate the Employment at any time with immediate effect and pay you a sum equal to
the basic salary you would have received during your notice period pursuant to clause 9.1 (or, if notice has already been given,
during the remainder of the notice period) less income tax and National Insurance contributions (“Payment in Lieu”).
The Payment in Lieu shall not include any payment in respect of:

 

		(a)	any
bonus or commission payments that might otherwise have been paid to you during the period for which the Payment in Lieu is made;

 

		(b)	benefits
                                         which you would have been entitled to receive during the period for which the Payment
                                         in Lieu is made; or

 

		(c)	any
                                         holiday entitlement that would have accrued to you during the period for which the Payment
                                         in Lieu is made.

 

		21.2	The
Company will make any payment pursuant to clause 21.1, at its absolute discretion, either within 28 days of the termination of
your employment or in equal monthly instalments in arrears until the date on which the period of notice referred to in clause
21.1 would have expired.

 

		21.3	You
shall have no right to receive a Payment in Lieu unless the Company has exercised its discretion in clause 21.1. Nothing in this
clause 21 shall prevent the Company from terminating your Employment in breach.

 

		21.4	If
having elected to make a Payment in Lieu but either before or after the payment (or any instalment of it) is made, it comes to
the Company’s attention that it may have been entitled to terminate your employment summarily for a reason within clause 23 or
otherwise, then the Company reserves the right not to make the Payment in Lieu (or any outstanding instalment of it) and/or to
demand the immediate repayment of it or any instalment which has already been paid.

 

		21.5	Notwithstanding
anything to the contrary herein, the following provisions apply to the extent the Payment in Lieu of notice provided herein is
subject to Section 409A of the Internal Revenue Code (the “Code”) and the regulations and other guidance thereunder
and any state law of similar effect (collectively “Section 409A”). The Payment in Lieu shall not commence until
the you have had a “separation from service” (as defined under Treasury Regulation Section 1.409A-1(h), without regard
to any alternative definition thereunder, a “separation from service”). Each installment of the Payment in Lieu is a
separate “payment” for purposes of Treas. Reg. Section 1.409A-2(b)(2)(i), and the Payments in Lieu are intended to satisfy
the exemptions from application of Section 409A provided under Treasury Regulations Sections 1.409A-1(b)(4), 1.409A-1(b)(5) and
1.409A-1(b)(9). However, if such exemptions are not available and you are, upon separation from service, a “specified employee”
for purposes of Section 409A, then, solely to the extent necessary to avoid adverse personal tax consequences under Section 409A,
the timing of the Payments in Lieu shall be delayed until the earlier of (i) six (6) months and one day after your separation
from service, (ii) your death or (iii) such earlier date as permitted under Section 409A without the imposition of adverse taxation.
Upon the first business day following the expiration of such applicable Section 409A period, all payments deferred pursuant to
this paragraph shall be paid in a lump sum to you, and any remaining payments due shall be paid as otherwise provided herein or
in the applicable agreement. No interest shall be due on any amounts so deferred. The parties acknowledge that the exemptions
from application of Section 409A to the Payments in Lieu are fact specific, and any later amendment of this Agreement to alter
the timing, amount or conditions that will trigger payment of the Payments in Lieu may preclude the ability of the Payments in
Lieu provided under this Agreement to qualify for an exemption. To the extent that the Payments in Lieu or other benefits are
deferred compensation under Section 409A, and are not otherwise exempt from the application of Section 409A, then, if the period
during which you may consider and sign the Release spans two calendar years, the payment of such severance payments and benefits
will not be made or begin until the later calendar year. It is intended that this Agreement shall comply with the requirements
of Section 409A, and any ambiguity contained herein shall be interpreted in such manner so as to avoid adverse personal tax consequences
under Section 409A. Notwithstanding the foregoing, the Company shall in no event be obligated to indemnify you for any taxes or
interest that may be assessed by the Internal Revenue Service pursuant to Section 409A of the Code to payments made pursuant to
this Agreement.

  

     12

     

    

 

		22.	Summary
Termination

 

		22.1	The
Company may terminate the Employment at any time, without notice or pay in lieu of notice, and with no liability to make any further
payment to you, save for the amounts accrued due to the Termination Date, if:

 

		(a)	you
                                         commit any act of gross misconduct;

 

		(b)	your
                                         conduct {whether or not it occurs during or in the context of the Employment) is such
                                         that it may in the reasonable opinion of the Board bring the Company and/or any Group
                                         Company into disrepute and/or is calculated or likely prejudicially to affect the interests
                                         of the Company and/or any Group Company;

 

		(c)	you
                                         are negligent and/or incompetent in the reasonable opinion of the Board in the performance
                                         of your Duties;

 

		(d)	you
                                         commit any serious or repeated breach of this Agreement;

 

		(e)	you
                                         are convicted of any criminal offence (other than an offence under the road traffic legislation
                                         in the United Kingdom or abroad for which you are not sentenced to any term of imprisonment,
                                         whether immediate or suspended);

 

		(f)	you
                                         commit any act of fraud or dishonesty or corrupt practice or a breach of the Bribery
                                         Act 2010 relating to the Company and/or any Group Company, any of its or their employees,
                                         customers or otherwise;

 

		(g)	you
                                         become prohibited by law from being a director, you are removed from office of director
                                         pursuant to the Company’s articles of association or you resign as a director other than
                                         with the prior written approval or at the written request of the Board or pursuant to
                                         clause 26;

 

		(h)	you
                                         become of unsound mind or a patient for the purposes of any statute relating to mental
                                         health so that in the opinion of the Board you are unable to perform your Duties;

 

		(i)	a
                                         bankruptcy petition is presented against you or you become bankrupt or an interim order
                                         is made in respect of you pursuant to section 252 of the Insolvency Act 1986 or you make
                                         any arrangement or composition with your creditors generally (including an Individual
                                         Voluntary Arrangement) or have a County Court administration order made against you under
                                         the County Court Act 1984.

 

		22.2	The
rights of the Company under clause 22.1 are without prejudice to any other rights that it may have at law to terminate the Employment
or accept any breach of this Agreement by you as having brought the Agreement to an end and any delay by the Company in exercising
its rights under clause 22.1 shall not constitute a waiver of such rights.

  

     13

     

    

 

		23.	Reconstruction
and Amalgamation

 

If
the Employment is terminated by reason of any reconstruction or amalgamation of the Company and/or any Group Company whether by
winding up or otherwise and you are offered employment with any concern or undertaking involved in or resulting from such reconstruction
or amalgamation on terms which (considered in their entirety) are no less favourable to any material extent than the terms of
this Agreement, you shall have no claim against the Company or any such undertaking arising out of or in connection with such
termination.

 

		24.	Obligations
after Employment

 

Without
prejudice to the other terms of this Agreement, you agree that following the termination of your Employment for any reason whatsoever,
you will be bound by and you will comply with the terms and conditions set out in Schedule 1 to this Agreement.

 

		25.	Property

 

At
any time during the Employment or following its termination (for whatever reason), as requested by the Company and/or any Group
Company, you agree to:

 

		(a)	return
                                         to the Company and/or any Group Company or irretrievably destroy or delete:

 

		(i)	any
documents, drawings, designs, computer files or software, visual or audio tapes or other materials containing information (including,
without limitation, Confidential Information) and/or any copies or extracts of the same relating to the Businesses; and

 

		(ii)	any
other property of the Company and/or any Group Company in your possession, custody and/or directly or indirectly under your control;

 

		(b)	inform
                                         the Company of all passwords, pass codes, pin numbers and any other similar information
                                         used by you in relation to any information technology systems, vehicles, rooms and/or
                                         any other secured property of the Company and/or any Group Company.

 

		26.	Resignation
from Appointments

 

		26.1	At
any time, at the request of the Company and/or any Group Company, you agree to resign from any directorships, offices, appointments
and/or trusteeships which you hold with the Company and/or any Group Company without claim for compensation and your resignation
shall not affect in anyway the continuance of this Agreement.

 

		26.2	You
irrevocably appoint the Company to be your attorney in your name and on your behalf to execute documents, use your name and do
all things which are necessary or desirable for the Company to obtain the full benefit of this clause.

 

		27.	Suspension

 

In
order to investigate a complaint against you of misconduct and/or poor performance, the Company may suspend you for so long as
may be necessary to carry out a proper investigation and complete any appropriate disciplinary and/or capability process. During
any period of suspension you shall continue to receive your salary and contractual benefits.

  

     14

     

    

 

		28.	Disciplinary
and Dismissal Rules

 

		28.1	You
are subject to the Company’s disciplinary rules and procedures in force from time to time a copy of which is available upon request
and such other procedures of this nature as may from time to time be adopted. Application of such procedure is at the Company’s
discretion and is not a contractual entitlement.

 

		28.2	If
you are dissatisfied with any disciplinary decision to dismiss you, you should refer such dissatisfaction in writing in accordance
with the applicable Company procedure.

 

		29.	Grievance

 

If
you have any grievance relating to the Employment (other than one relating to a disciplinary decision or a decision to dismiss
you), you should refer such grievance in writing in accordance with the Company’s grievance procedure in force from time to time
(a copy of which is available upon request). If the grievance is not resolved at this stage, you can appeal in accordance with
the appeal procedure set out in the appropriate procedure. Application of the grievance procedure is discretionary and not a contractual
entitlement.

 

		30.	Data
Protection

 

		30.1	The
Company and any Group Company shall process your personal data (including, where necessary, sensitive personal data, such terms
being defined in the Data Protection Act 1998) in their paper-based and computerised systems. You consent to the processing of
such data both inside and, where necessary, outside the European Economic Area for the purposes of:

 

		(a)	salary,
benefits and pensions administration and employee management;

 

		(b)	health
administration and for the purposes of health insurance/benefits;

 

		(c)	training
and appraisal, including performance records and disciplinary records;

 

		(d)	equal
opportunities monitoring;

 

		(e)	any
potential change of control of the Company and/or Group Company, or any potential transfer of employment under the Transfer of
Undertakings (Protection of Employment) Regulations 2006. In such circumstances, disclosure may include disclosure to the potential
purchaser or investor and their advisors;

 

		(f)	promoting
or marketing of the Company and/or any Group Company and/or its or their products or services;

 

		(g)	compliance
with applicable procedures, laws and regulations; and/or

 

		(h)	any
other reasonable purposes in connection with your employment about which you shall be notified from time to time.

 

		30.2	You
acknowledge and accept that in order to fulfil the purposes set out above, it may be necessary to pass your personal data (or
sensitive personal data, as appropriate) to regulatory bodies, government agencies and other third parties as required by law
or for administration purposes.

 

		30.3	You
acknowledge and accept that the Company and/or any Group Company may monitor electronic correspondence (including email, voice
and text messages) which you receive at work and/or on Company systems and/or property provided to you by the Company and/or any
Group Company for the purposes of your work in order to ensure the integrity of its information technology or to prevent or detect
criminal behaviour or behaviour which contravenes employment legislation and/or other Company and/or Group Company policies.

   

		30.4	You
agree to use all reasonable endeavours to keep the Company informed of any changes to your personal data or sensitive personal
data and to comply with all relevant data protection legislation.

  

     15

     

    

 

		31.	Warranty

 

		31.1	You
warrant that you are not bound by nor subject to any court order, arrangement, obligation (express or implied), restriction or
undertaking (contractual or otherwise) which prohibits or restricts you from entering into this Agreement or performing the Duties.

 

		31.2	You
undertake to indemnify the Company and/or any Group Company against any claims, costs, damages, liabilities and/or expenses which
the Company and/or any Group Company may incur as a result of any claim that you are in breach of any order, arrangement, obligation,
restriction or undertaking referred to in clause 31.1.

 

		31.3	You
warrant that you are entitled to work in the United Kingdom without any additional approvals and will notify the Company immediately
if you cease to be so entitled during the course of your employment.

 

		31.4	You
warrant that you have no previous convictions and have not previously been reported for or been subject to investigation for bribery
related offences including, without limitation, offences under the Bribery Act 2010.

 

		32.	Deductions

 

You
agree that at any time the Company may deduct from your salary or any other sums owed to you any money you owe to the Company
and/or any Group Company.

 

		33.	Power
of Attorney

 

If
you fail to comply with any request(s) under clauses 19 and/or 26, you irrevocably authorise the Company and/or any Group Company
to appoint a person in your name and on your behalf to sign any documents or do any things necessary or requisite for the purposes
of giving the Company and/or any Group Company and its or their nominee the full benefit of such clauses.

 

		34.	Collective
Agreements

 

There
are no collective agreements which affect the terms and conditions of your employment.

 

		35.	Entire
Agreement

 

This
Agreement sets out the entire agreement and understanding between the parties and supersedes all prior agreements, understandings
or arrangements (oral or written) in respect of your employment or engagement by the Company. No purported variation of this Agreement
shall be effective unless it is in writing and signed by or on behalf of each of the parties.

 

The
parties agree that the letter agreement between the parties dated 14 January 2019 which purported to amend and restate the original
agreement between the parties dated 1 September 2017 in its entirety is to be treated as void, and that this Agreement shall be
effective.

 

You
further agree that your continued employment is contingent on you continuing to abide by the Proprietary Information, Inventions,
Non-Solicitation and Non-Competition Agreement that you previously executed. The Proprietary Information, Inventions, Non-Solicitation
and Non- Competition Agreement is not affected by this Agreement, and to the extent that the terms in this Agreement conflict
with the terms in that agreement, the terms in that agreement shall take primacy.

 

		36.	Third
Parties

 

Unless
expressly provided in this Agreemen1t6, no term of this Agreement is enforceable pursuant to the Contracts (Rights of Third Parties)
Act 1999 by any person who is not a party to it.

  

     16

     

    

 

		37.	Releases
and waivers

 

		37.1	The
Company may, in whole or in part, release, compound, compromise, waive or postpone, in its absolute discretion, any liability
owed to it or right granted to it in this Agreement by you without in any way prejudicing or affecting its rights in respect of
any part of that liability or any other liability or right not so released, compounded, compromised, waived or postponed.

 

		37.2	No
single or partial exercise, or failure or delay in exercising any right, power or remedy by the Company shall constitute a waiver
by it of, or impair or preclude any further exercise of, that or any right, power or remedy arising under this Agreement or otherwise.

 

		38.	Notices

 

		38.1	Any
notice to a party under this Agreement shall be in writing signed by or on behalf of the party giving it and shall, unless delivered
to a party personally, be hand delivered, or sent by prepaid first class post or facsimile.

 

		38.2	A
notice shall be deemed to have been served:

 

		(a)	at
the time of delivery if delivered personally to a party or to the specified address;

 

		(b)	on
the second working day after posting by first class prepaid post; or

 

		(c)	2
hours after transmission if served by facsimile on a business day prior to 3pm or in any other case at 10 am on the business day
after the date of despatch.

 

		39.	Variation

 

No
variation or agreed termination of this Agreement shall be effective unless it is in writing and signed by the parties (or their
authorised representatives).

 

		40.	Counterparts

 

		40.1	This
Agreement may be executed in any number of counterparts, each of which when executed and delivered shall constitute a duplicate
original, but all the counterparts shall together constitute the one agreement.

 

		40.2	No
counterpart shall be effective until each party has executed and delivered at least one counterpart.

 

		41.	Governing
law and jurisdiction

 

		41.1	This
Agreement shall be governed by and construed in accordance with English law.

 

		41.2	Each
of the parties irrevocably submits for all purposes in connection with this Agreement to the exclusive jurisdiction of the English
courts.

 

		42.	Miscellaneous

 

The
vesting of any unvested employee share incentives held by you will accelerate in the event that your employment is
terminated without cause, or if you resign for good reason (which shall be determined at the Company’s sole discretion,
acting reasonably and in good faith) and, in each case, such termination is upon the consummation of or within 12 months
following a change of control of the Company. If your employment with the Company is terminated without cause, or if you
resign for good reason (which shall be determined at the Company’s sole discretion, acting reasonably and in good
faith), you will also be entitled to receive severance equal to continuation of your base salary as then currently in effect
(pursuant to Clause 9) for 12 months following your date of termination and will be eligible for reimbursement for medical
coverage premiums for up to the same period. 1Y7ou, your spouse and eligible dependents are entitled to stay on our health
insurance plans for a period of 12 months following your termination for any reason. Your severance benefits are conditioned
on your execution of the Company’s standard separation agreement and a general release of claims in the Company’s
favor.

 

In
witness this Deed has been executed on the date appearing at the head of page 1.

  

     17

     

    

 

Schedule
1

 

(Post
termination

 restrictions)

  

		1.	Definitions
and interpretation

 

		1.1	In
this Schedule, unless the context otherwise requires, the following additional definitions shall apply (in addition to the definitions
contained in the Agreement to which this Schedule is annexed and of which it forms a part):

 

“the
Business” means the business of the Company or any part thereof and any other business or part thereof carried on by
any Group Company as at the Termination Date and/or during the Protected Period and in respect of which the Duties have been materially
concerned or about which you have acquired Confidential Information.

 

“Customer”
means any person who at any time during the Protected Period was a customer of the Company or any Group Company and was a
person with whom you had material personal dealings or in relation to whom you have acquired Confidential Information.

 

“Garden
Leave Period” means any period during which the Company has exercised its rights pursuant to clause 20 of the Agreement
to which this Schedule is annexed.

 

“Goods
and/or Services” means any goods and/or services competitive with those supplied by the Company or any Group Company
at any time during the Protected Period and in relation to which you were materially involved or concerned or for which you were
responsible during that period.

 

“Key
Employee” means any person who at any time during the Protected Period is or was employed or engaged by the Company or
any Group Company in a senior managerial, sales, marketing, technical or supervisory capacity and with whom you dealt during that
period.

 

“Prospective
Customer” means any person who was at any time during the Protected Period engaged in negotiations, with which you were
personally involved, with the Company or any Group Company with a view to obtaining goods or services from the Company or any
Group Company or in relation to whom you have acquired Confidential Information.

 

“Protected
Period” means the 12 months immediately preceding the earlier of the Termination Date and the commencement of any Garden
Leave Period.

 

“Restriction
Period” means the period of 6 months following the Termination Date less any Garden Leave period.

 

“Supplier”
means any person with whom you have had material dealings as part of the Duties during the Protected Period and who has during
that period supplied goods or services to the Company or any Group Company on terms other than those available to another purchaser
in the market during that period, whether by reason of exclusivity (either de facto or contractually obliged), price or otherwise.

 

		2.	Obligations
after employment

 

		2.1	You
shall not for the Restriction Period hold a Material Interest in a business or venture which:

 

		(a)	is
or is about to be in competition with the Business or any part thereof; or

 

		(b)	is
likely to result in the intentional or unintentional disclosure or use of Confidential Information by you in order for you to
properly discharge your duties to or further your interest in that business or venture.

  

     18

     

    

  

		2.2	The
provisions of clause 2.1 shall not operate so as to prevent you from being engaged, concerned or interested in any business or
venture in so far as your work for that business or venture shall relate solely to services or activities with which the Duties
were not concerned to a material extent or in relation to which you were not responsible and in relation to which you held no
Confidential Information during the Protected Period.

 

		2.3	You
shall not for the Restriction Period in respect of any Goods and/or Services:

 

		(a)	deal
with or supply any Customer;

 

		(b)	deal
with or supply any Prospective Customer; or

 

		(c)	offer
employment or any contract for services to or employ or engage any Key Employee.

 

		2.4	You
shall not for the Restriction Period in respect of any Goods and/or Services:

 

		(a)	solicit,
facilitate the solicitation of or canvass the custom or business of any Customer;

 

		(b)	solicit,
facilitate the solicitation of or canvass the custom or business of any Prospective Customer; or

 

		(c)	solicit
or entice or endeavour to solicit or entice any Key Employee to leave his employment with or cease his directorship or consultancy
with the Company or any Group Company, whether or not that person would breach any obligations owed to the Company or any relevant
Group Company by so doing.

 

		2.5	You
shall not for the Restriction Period:

 

		(a)	deal
with or accept the supply of any goods or services from any Supplier where such supply is likely to be the detriment of any Group
Company whether by causing the Supplier to reduce or alter the terms or quantity of supply to the Group Company or where the value
of the Company’s arrangement with the Supplier is diminished; or

 

		(b)	solicit,
facilitate the solicitation of or canvass the supply of any goods or services from any Supplier where such supply is likely to
be the detriment of any Group Company whether by causing the Supplier to reduce or alter the terms or quantity of supply to the
Group Company or where the value of the Group Company’s arrangement with the Supplier is diminished;

 

		2.6	If,
at any time during the Employment, two or more Key Employees leave the employment of the Company or any Group Company to provide
Goods and/or Services for the same business or venture, you shall not, at any time during the 6 months following the last date
on which any of those Key Employees was employed by the Company or any Group Company, be employed or engaged in any way with that
business or venture in respect of any Goods and/or Services.

 

		2.7	You
shall not at any time after the Termination Date:

  

		(a)	induce
or seek to induce by any means involving the disclosure or use of Confidential Information any Customer or Supplier to cease dealing
with the Company or any Group Company or to restrict or vary the terms upon which it deals with the relevant Group Company;

 

		(b)	be
held out or represented by you or any other person as being in any way connected with or interested in the Company or any Group
Company; or

    

		(c)	disclose
to any person or make use of any Confidential Information (except as required by law).

  

     19

     

    

 

		3.	General

 

		3.1	You
have given the undertakings in this Schedule to the Company as trustee for itself and each Group Company in the business of which
you have been concerned or involved to any material extent during the Employment or which benefits from each undertaking. You
agree that each such Group Company may enforce the benefit of each such undertaking. You shall, at the request and expense of
the Company, enter into direct undertakings with any such Group Company which correspond to the undertakings in this Schedule.

 

		3.2	You
agree that if the Company transfers all or any part of its business to a third party (“transferee”), the restrictions
contained in this Schedule 1 shall, with effect from the date of you becoming an employee of the transferee, apply to you as if
references to the Company included the transferee and references to any Group Companies were construed accordingly and as if references
to customers or suppliers were of the Company and/or the transferee and their respective Group Companies.

 

		3.3	You
agree that if you have material business dealings in other foreign jurisdictions on behalf of any Group Company, you will enter
into undertakings providing the same level of protection for each such Group Company with such modifications (if any) as are necessary
to render such undertakings enforceable in those jurisdictions.

 

		3.4	You
acknowledge that you have had the opportunity to take independent legal advice in relation to the undertakings contained in this
Schedule.

 

		3.5	The
obligations imposed on you by this Schedule extend to you acting not only on your own account but also on behalf of any other
firm, company or other person and shall apply whether you act directly or indirectly.

 

		3.6	You
warrant that you believe the covenants contained within this Schedule to be reasonable as between the parties and that you have
no present intention of ever arguing that the restraints are unreasonable or otherwise unenforceable.

  

     20

     

    

 

Executed
as a Deed

by Kunwar Shailubhai

/s/ Kunwar Shailubhai

 

in the presence of:

 

Signature of witness:

 

/s/ Edward Lukins

 

Name:
Edward Lukins

 

Address:
Dashwood

 69 Old Broad Street London

 

Occupation:
Solicitor

 

Executed as a Deed

(but not delivered until the date)

appearing at the head of page 1)) by

Tiziana Lifesciences plc
acting by 

Gabriele Cerrone

a director in the presence of

 

/s/ Gabriele Cerrone

 

Signature of witness:

 

	/s/ Tiziano Lazzaretti
	 
	Name: Tiziano Lazzaretti,
	 
	Address: 55 Park Avenue London

                                 W1K 1MA

  

Occupation: 

 

21Exhibit

SEVENTH AMENDMENT TO THIRD AMENDED AND RESTATED  
REVOLVING LOAN AND SECURITY AGREEMENT AND OMNIBUS RELEASE

THIS SEVENTH AMENDMENT TO THIRD AMENDED AND RESTATED REVOLVING LOAN AND SECURITY AGREEMENT AND OMNIBUS RELEASE (this “Amendment”) dated as of May 13, 2019, is by and among CIBC BANK USA, formerly known as The PrivateBank and Trust Company, an Illinois banking corporation (together with its successors and assigns, “Administrative Agent”) in its capacity as administrative agent for the Lenders (as defined below), the Lenders, DIVERSICARE MANAGEMENT SERVICES CO., a Tennessee corporation, and certain of its affiliates parties hereto identified on the signature pages as “Borrower” (individually and collectively, “Borrower”).  
RECITALS:
WHEREAS, Borrower, Administrative Agent, and the financial institutions signatories thereto (the “Lenders”) are parties to that certain Third Amended and Restated Revolving Loan and Security Agreement dated as of February 26, 2016 (as the same has been, and may hereafter be, amended, restated, supplemented or otherwise modified from time to time, the “Loan Agreement”; all capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Loan Agreement as amended by this Amendment); 
WHEREAS, Borrower has requested that DIVERSICARE HILLCREST, LLC, DIVERSICARE LAMPASAS, LLC, DIVERSICARE YORKTOWN, LLC, and DIVERSICARE HUMBLE, LLC (individually and collectively, the “Released Borrower”) be removed as a party to the Loan Agreement and the Financing Agreements to which it is a party and Administrative Agent release all Liens in favor of Administrative Agent, for the benefit of the Lenders, in the assets and property of the Released Borrower and Administrative Agent and the Lenders have agreed to such removal and release, in each case as provided in, and subject to the terms and conditions of, this Agreement;
WHEREAS, Borrower, Administrative Agent and Lenders desire to amend the Loan Agreement as provided in and subject to the terms and conditions of this Amendment;
NOW, THEREFORE, for and in consideration of the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto (intending to be legally bound) hereby agree as follows:
1.Amendments to Loan Agreement.  Subject to the satisfaction of the conditions set forth in Section 5 below and in reliance upon the representations and warranties set forth in Section 4 below, Borrower, Administrative Agent and Lenders hereby amend the Loan Agreement as follows:
(a)    Section 1.1 of the Loan Agreement is hereby amended by amending and restating the following definitions therein to read as follows:

“Adjusted EBITDA” means, on a consolidated basis for the applicable Person, the sum of (a) EBITDA (which calculation shall not include or extend to Hospital District (as defined in the Affiliate Revolving Loan Agreement) or any QIPP Funds (as defined in the Affiliate Revolving Loan Agreement)), and (b) the amounts deducted (or less amounts added) in computing EBITDA for the period for (i) the non-cash provision (benefit) for self-insured professional and general liability expenses, (ii) non-cash rent expense, (iii) non-cash stock based compensation expense, (iv) non-cash debt retirement, and (v) all other non-cash expenses reasonably approved by the Administrative Agent, less (c) the Cash Cost of Self-Insured Professional and General Liability.
“Fixed Charge Coverage Ratio” means, on any date of determination, the ratio of (a) Adjusted EBITDAR (QIPP Funds) for the period of 12 consecutive months then ended, to (b) Fixed Charges, all as determined for the Parent, the Borrower and the Affiliate Revolving Borrowers on a consolidated basis, all as determined in accordance with GAAP, consistently applied.
“Maximum Revolving Facility” means an amount equal to Forty Million Two Hundred Fifty Thousand and No/100 Dollars ($40,250,000.00).
(b)    Section 1.1 of the Loan Agreement is hereby amended by adding the following definitions in alphabetical order:
“Adjusted EBITDA (QIPP Funds)” means, on a consolidated basis for the applicable Person, the sum of (a) EBITDA (which calculation, for the avoidance of doubt, shall not include or extend to Hospital District (as defined in the Affiliate Revolving Loan Agreement), but shall include Affiliate Revolving Borrower’s and any Borrower’s portion of QIPP Funds (as defined in the Affiliate Revolving Loan Agreement), as applicable), and (b) the amounts deducted (or less amounts added) in computing EBITDA for the period for (i) the non-cash provision (benefit) for self-insured professional and general liability expenses, (ii) non-cash rent expense, (iii) non-cash stock based compensation expense, (iv) non-cash debt retirement, and (v) all other non-cash expenses reasonably approved by the Administrative Agent, less (c) the Cash Cost of Self-Insured Professional and General Liability.
“Adjusted EBITDAR (QIPP Funds)” means (a) Adjusted EBITDA (QIPP Funds) plus (b) cash rent expense (rent expense adjusted to remove effects of non-cash rent).
“Affiliate Revolving Borrowers” means each of the “Borrowers” party to the Affiliate Revolving Loan Agreement as a “Borrower” from time to time.
“Affiliate Revolving Loan” means, collectively, those certain revolving loans made by the Lenders to the Affiliate Revolving Borrowers from time to time pursuant to the Affiliate Revolving Loan Agreement.
“Affiliate Revolving Loan Agreement” means that certain Revolving Loan and Security Agreement dated as of May 13, 2019 by and among DIVERSICARE MANAGEMENT SERVICES CO., a Tennessee corporation, in its capacity as borrowing agent for the Affiliate Revolving Borrowers, the Affiliate Revolving Borrowers, the Lenders and the Administrative Agent, as the same may be restated, modified, supplemented or amended from time to time.
“Affiliate Revolving Loan Financing Agreement” means each “Financing Agreement” as defined in the Affiliate Revolving Loan Agreement, as any of the same may be restated, modified, supplemented or amended from time to time.
“Affiliate Revolving Loan Liabilities” means the “Liabilities” as defined in the Affiliate Revolving Loan Agreement.
(c)    The first sentence of Section 6.6 is hereby amended and restated to read as follows:  “All Liabilities of the Borrowers under this Agreement and each of the Financing Agreements, and all of the Affiliate Term Loan Liabilities under the Term Loan Agreement and each of the Affiliate Term Loan Financing Agreements, are cross-collateralized and (y) all Liabilities of the Borrowers under this Agreement and each of the Financing Agreements, all of the Affiliate Term Loan Liabilities under the Term Loan Agreement and each of the Affiliate Term Loan Financing Agreements and all of the Affiliate Revolving Loan Liabilities under the Affiliate Revolving Loan Agreement and each of the Affiliate Revolving Loan Financing Agreements are cross-defaulted.”
(d)    Section 7.28 of the Loan Agreement is hereby amended and restated in its entirety to read as follows:
7.28    Consideration.  Each Borrower (including the Affiliated Term Borrowers and Affiliate Revolving Borrowers) is a direct or indirect subsidiary of Parent, and are Affiliates of each other.  The Affiliates of the Borrower will derive substantial direct and indirect benefit (financial and otherwise) from funds made available to the Borrower pursuant to this Agreement, and it is and will be to such Affiliates’ advantage to assist the Borrower in procuring such funds from the Lenders.  Each of the Borrower’s Affiliates desires to induce the Lender to enter into this Agreement with the Borrower.  Each Borrower will derive substantial direct and indirect benefit (financial and otherwise) from funds made available to Affiliated Term Borrowers pursuant to the Term Loan Agreement (including without limitation any “Acquisition Loan” made thereunder) and Affiliate Revolving Borrowers pursuant to the Affiliate Revolving Loan Agreement, and it is and will be to Borrower’s, Affiliated Term Borrower’s and Affiliate Revolving Borrower’s advantage to assist each other in procuring such funds from Lenders.
(e)    Section 9.3 is hereby amended to add “or Affiliate Revolving Loan Borrower” immediately after “Affiliated Term Loan Borrower”.
(f)    Section 9.12 (a) is hereby amended to add “and Affiliate Revolving Borrowers,” immediately after “The Parent and Borrowers,”. Section 9.12 (b) is hereby amended to add “and Affiliate Revolving Borrowers,” immediately after “The Parent and Borrowers,”.
(g)    Section 11.1(dd) is hereby amended and restated in its entirety to read as follows:
(dd)    an “Event of Default” shall occur under or pursuant to the Term Loan Agreement, any Affiliate Term Loan Financing Agreement, the Affiliate Revolving Loan Agreement or any Affiliate Revolving Loan Financing Agreement.
(h)    Section 12.21(b) is hereby amended to amend and restate the last sentence therein to read as follows:  “Each Borrower has determined that it is in its best interest to procure the Loan with the credit support of the other Borrowers as contemplated by this Agreement and the other Financing Agreements as well as permit the cross-collateralization with the Affiliate Revolving Loan Liabilities, Revolving Loan Agreement and Affiliate Revolving Loan Financing Agreements and cross-default with the Affiliate Revolving Loan Liabilities, Revolving Loan Agreement and Affiliate Revolving Loan Financing Agreements and Affiliate Term Loan Liabilities, Term Loan Agreement and Affiliate Term Loan Financing Agreements as contemplated hereunder.”
(i)    Annex A (Lenders, Pro Rata Shares/Dollar Allocations, and Notice Information) to the Loan Agreement shall be amended and restated and replaced with Annex A attached hereto.  
2.    Release.  Subject to the terms and conditions contained herein and notwithstanding anything contained in the Financing Agreements to the contrary:
(a)    From and after the date hereof, (i) each Released Borrower is released as a Borrower under the Loan Agreement and Subsidiary under the applicable Pledge Agreement and all references to “Borrower” in the Loan Agreement or any of the Financing Agreements to which it is a party or “Subsidiary” under the applicable Pledge Agreement are amended to remove such Released Borrower from therewith, and (ii) all Liens in favor of Administrative Agent, for the benefit of the Lenders, on the assets and property of each Released Borrower are released.
(b)    All obligations of the Released Borrower (other than contingent indemnification obligations), in its capacity as a Borrower, created by the Financing Agreements, or in its capacity as a Subsidiary, created under the applicable Pledge Agreement, are hereby released without any further action by any party hereto.
3.    No Other Amendments.  Borrower acknowledges and expressly agrees that this Amendment is limited to the extent expressly set forth herein and shall not constitute a modification or amendment of the Loan Agreement or any other Financing Agreements or a course of dealing at variance with the terms or conditions of the Loan Agreement or any other Financing Agreements (other than as expressly set forth in this Amendment and the other instruments, agreements, certificates and documents required to be executed and delivered in connection herewith).
4.    Representations and Warranties.  In order to induce Administrative Agent and Lenders to enter into this Amendment, Borrower hereby represents and warrants to Administrative Agent and Lenders (which representations and warranties shall survive the execution and delivery hereof), both before and after giving effect to this Amendment that:
(a)    Each of the representations and warranties of each Borrower contained in the Loan Agreement and the other Financing Agreements to which Borrower is a party are true and correct in all material respects (without duplication of any materiality carve out already provided therein) on and as of the date hereof, in each case as if made on and as of such date, other than representations and warranties that expressly relate solely to an earlier date (in which case such representations and warranties were true and correct on and as of such earlier date);
(b)    Borrower has the corporate or limited liability company (as applicable) power and authority (i) to enter into the Loan Agreement as amended by this Amendment and (ii) to do all acts and things as are required or contemplated hereunder to be done, observed and performed by Borrower;
(c)    This Amendment has been duly authorized, validly executed and delivered by one or more Duly Authorized Officers of Borrower, and each of this Amendment, the Loan Agreement as amended hereby, and each of the other Financing Agreements to which Borrower is a party, constitutes the legal, valid and binding obligations of Borrower, enforceable against Borrower in accordance with their respective terms, subject to bankruptcy, insolvency or other similar laws affecting the enforcement of creditor’s rights and remedies generally;
(d)    The execution and delivery of this Amendment and performance by Borrower under this Amendment, the Loan Agreement and each of the other Financing Agreements to which Borrower is a party do not and will not require the consent or approval of any regulatory authority or governmental authority or agency having jurisdiction over Borrower that has not already been obtained, nor be in contravention of or in conflict with the organizational documents of Borrower, or any provision of any statute, judgment, order, indenture, instrument, agreement, or undertaking, to which Borrower is party or by which Borrower’s respective assets or properties are bound; and
(e)    No Default or Event of Default will result after giving effect to this Amendment, and no event has occurred that has had or could reasonably be expected to have a Material Adverse Effect after giving effect to this Amendment. 
5.    Conditions Precedent to Effectiveness of this Amendment.  The amendments contained in Section 1 and the release contained in Section 2 of this Amendment shall become effective on the date hereof as long as each of the following conditions precedent is satisfied as determined by Administrative Agent:
(a)    all of the representations and warranties of Borrower under Section 4 hereof, which are made as of the date hereof, are true and correct;
(b)    Administrative Agent shall have received a duly executed signature pages to this Amendment from Borrower and Lenders;
(c)    Administrative Agent shall have received a duly executed Reaffirmation of Second Amended and Restated Guaranty in the form attached hereto;
(d)    Administrative Agent shall have received a duly executed Reaffirmation of Pledge Agreements in the form attached hereto; 
(e)    Administrative Agent shall have received a duly executed amendment to the Omega Intercreditor Agreement;
(f)    Administrative Agent shall have received the amount of reasonable fees and out-of-pocket costs and expenses of counsel to Administrative Agent in connection with the Amendment pursuant to Section 8 hereof and otherwise due and owing pursuant to the Loan Agreement; and
(g)    Administrative Agent shall have received such other certificates, schedules, exhibits, documents, opinions, instruments, reaffirmations, amendments or consents that Administrative Agent may reasonably require, if any.
6.    Reaffirmation; References to Loan Agreement; Additional Agreements and Covenants; Etc.
(a)    Borrower acknowledges and agrees that all of Borrower’s obligations and Liabilities under the Loan Agreement and the other Financing Agreements, as amended hereby, are and shall be valid and enforceable and shall not be impaired or limited by the execution or effectiveness of this Amendment.  The first priority perfected security interests and Liens and rights in the Collateral securing payment of the Liabilities are hereby ratified and confirmed by Borrower in all respects.
(b)    Upon the effectiveness of this Amendment, each reference in the Loan Agreement to “this Agreement,” “hereunder,” “hereof,” “herein” or words of like import shall mean and be a reference to the Loan Agreement, as amended by this Amendment.
(c)    The failure by Administrative Agent, at any time or times hereafter, to require strict performance by any Borrower of any provision or term of the Loan Agreement, this Amendment or any of the Financing Agreements shall not waive, affect or diminish any right of Administrative Agent hereafter to demand strict compliance and performance herewith or therewith.  Any suspension or waiver by Administrative Agent of a breach of this Amendment or any Event of Default under or pursuant to the Loan Agreement shall not, except as expressly set forth in a writing signed by Administrative Agent, suspend, waive or affect any other breach of this Amendment or any Event of Default under or pursuant to the Loan Agreement, whether the same is prior or subsequent thereto and whether of the same or of a different kind or character.  None of the undertakings, agreements, warranties, covenants and representations of any Borrower contained in this Amendment, shall be deemed to have been suspended or waived by Administrative Agent unless such suspension or waiver is (i) in writing and signed by Administrative Agent (and, if applicable, the Required Lenders) and (ii) delivered to Borrower by Administrative Agent or its counsel.
(d)    In no event shall Administrative Agent’s execution and delivery of this Amendment establish a course of dealing among Administrative Agent, any Borrower, pledgor or Guarantor or any other obligor, or in any other way obligate Administrative Agent to hereafter provide any amendments or modifications or, if at any time applicable, consents or waivers with respect to the Loan Agreement or any other Financing Agreement.  The terms and provisions of this Amendment shall be limited precisely as written and shall not be deemed (x) to be a consent to any amendment or modification of any other term or condition of the Loan Agreement or of any of the Financing Agreements (except as expressly provided herein or in any of the other instruments, agreements, certificates and documents required to be executed and delivered in connection herewith); or (y) to prejudice any right or remedy which Administrative Agent or the Lenders may now have under or in connection with the Loan Agreement or any of the other Financing Agreements.  In the event an ambiguity or question of intent or interpretation arises, this Amendment shall be construed as if drafted jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any of the provisions of this Amendment.
(e)    Except as expressly provided herein (or in any of the other instruments, agreements, certificates and documents required to be executed and delivered in connection herewith), the Loan Agreement and all of the other Financing Agreements shall remain unaltered, and the Loan Agreement and all of the other Financing Agreements shall remain in full force and effect and are hereby ratified and confirmed in all respects.
7.    Release.
(a)    In consideration of, among other things, the consent and amendments provided for herein, and for other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, Borrower and Guarantor (on behalf of themselves and their respective subsidiaries, Affiliates, successors and assigns), and, to the extent permitted by applicable law and the same is claimed by right of, through or under the above, for their past, present and future employees, directors, members, managers, partners, agents, representatives, officers, directors, and equity holders (all collectively, with Borrower and Guarantor, the “Releasing Parties”), do hereby unconditionally, irrevocably, fully, and forever remise, satisfy, acquit, release and discharge Administrative Agent, Issuing Lender, and Lenders and each of Administrative Agent’s, Issuing Lender’s and Lender’s past, present and future officers, directors, agents, employees, attorneys, parent, shareholders, successors, assigns, subsidiaries and Affiliates and all other persons and entities to whom Administrative Agent or Lenders would be liable if such persons or entities were found in any way to be liable to any of the Releasing Parties (collectively, the “Lender Parties”), of and from any and all manner of action and actions, cause and causes of action, claims, cross-claims, charges, demands, counterclaims, suits, proceedings, disputes, debts, dues, sums of money, accounts, bonds, covenants, contracts, controversies, damages, judgments, liabilities, damages, costs, expenses, executions, liens, claims of liens, claims of costs, penalties, attorneys’ fees, or any other compensation, recovery or relief on account of any liability, obligation, demand, proceedings or cause of action of whatever nature, whether in law, equity or otherwise (including, without limitation, those arising under 11 U.S.C. §§ 541-550 and interest or other carrying costs, penalties, legal, accounting and other professional fees and expenses, and incidental, consequential and punitive damages payable to third parties), whether known or unknown, fixed or contingent, joint and/or several, secured or unsecured, due or not due, primary or secondary, liquidated or unliquidated, contractual or tortious, direct, indirect, or derivative, asserted or unasserted, foreseen or unforeseen, suspected or unsuspected, now existing, heretofore existing or which may have heretofore accrued against any or all of Lender Parties, whether held in a personal or representative capacity, that the Releasing Parties (or any of them) have or may have against the Lender Parties or any of them (whether directly or indirectly) and which are based on any act, fact, event, action or omission or any other matter, condition, cause or thing occurring at or from any time prior to and including the date hereof in any way, directly or indirectly arising out of, connected with or relating to this Amendment, the Loan Agreement or any other Financing Agreement and the transactions contemplated hereby and thereby, the Collateral or the Liabilities, and all other agreements, certificates, instruments and other documents and statements (whether written or oral) related to any of the foregoing, other than any applicable good faith claim as to which a final determination is made in a judicial proceeding (in which Administrative Agent and any of the Released Parties have had an opportunity to be heard) which determination includes a specific finding that Administrative Agent acted in a grossly negligent manner or with actual willful misconduct or illegal activity.  Borrower and Guarantor each acknowledges that Administrative Agent and Lenders are specifically relying upon the representations, warranties and agreements contained herein and that such representations, warranties and agreements constitute a material inducement to Administrative Agent and Lenders in entering into this Amendment.
(b)    Borrower and Guarantor each understands, acknowledges and agrees that the release set forth above may be pleaded as a full and complete defense and may be used as a basis for an injunction against any action, suit or other proceeding which may be instituted, prosecuted or attempted in breach of the provisions of such release.
(c)    To the furthest extent permitted by law, Borrower and Guarantor each hereby knowingly, voluntarily, intentionally and expressly waives and relinquishes any and all rights and benefits that it respectively may have as against Lender Parties under any law, rule or regulation of any jurisdiction that would or could have the effect of limiting the extent to which a general release extends to claims which a Lender Party or Releasing Party does not know or suspect to exist as of the date hereof.  Borrower and Guarantor each hereby acknowledges that the waiver set forth in the prior sentence was separately bargained for and that such waiver is an essential term and condition of this Amendment (and without which the amendment in Section 1 and the release in Section 2 hereof would not have been agreed to by Administrative Agent and Lenders).
8.    Costs and Expenses.  Without limiting the obligation of Borrower to reimburse Administrative Agent for all costs, fees, disbursements and expenses incurred by Administrative Agent as specified in the Loan Agreement, Borrower agrees to and shall pay on demand all reasonable costs, fees, disbursements and expenses of Administrative Agent in connection with the preparation, negotiation, revision, execution and delivery of this Amendment and the other agreements, amendments, modifications, reaffirmations, instruments and documents contemplated hereby, including, without limitation, reasonable attorneys’ fees and out-of-pocket expenses. All obligations provided herein shall survive any termination of this Amendment and the Loan Agreement as amended hereby.
9.    Financing Agreement.  This Amendment shall constitute a Financing Agreement.
10.    Titles.  Titles and section headings herein shall be without substantive meaning and are provided solely for the convenience of the parties.
11.    Severability; Etc.  Whenever possible, each provision of this Amendment shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Amendment shall be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Amendment.  The parties hereto have participated jointly in the negotiation and drafting of this Amendment.  In the event an ambiguity or question of intent or interpretation arises, this Amendment shall be construed as if drafted jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any of the provisions of this Amendment.
12.    Successors and Assigns.  This Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns; provided, however, no Borrower may assign any of its respective rights or obligations under this Amendment without the prior written consent of Administrative Agent.
13.    Further Assurances.  Borrower shall, at its own cost and expense, cause to be promptly and duly taken, executed, acknowledged and delivered all such further acts, certificates, instruments, reaffirmations, amendments, documents and assurances as may from time to time be necessary or as Administrative Agent may from time to time reasonably request in order to more fully carry out the intent and purposes of this Amendment or any of the other instruments, agreements, certificates and documents required to be executed and delivered in connection herewith.
14.    Counterparts; Faxes.  This Amendment may be executed in multiple counterparts, each of which shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement.  A signature hereto sent or delivered by facsimile or other electronic transmission shall be as legally binding and enforceable as a signed original for all purposes.
15.    Governing Law.  This Amendment shall be governed by and construed and enforced in accordance with the internal laws of the State of Illinois, without regard to conflict of law principles that would require the application of any other laws.
[Signature Pages Follow]

IN WITNESS WHEREOF, the parties hereto have duly executed this Seventh Amendment to Third Amended and Restated Revolving Loan and Security Agreement and Omnibus Release as of the day and year first above written.

	
			
	BORROWER: 
 
ADVOCAT FINANCE, INC. 
DIVERSICARE MANAGEMENT SERVICES CO. 
DIVERSICARE LEASING CORP. 
STERLING HEALTH CARE MANAGEMENT, INC. 
DIVERSICARE TEXAS I, LLC 
DIVERSICARE HOLDING COMPANY, LLC 
DIVERSICARE KANSAS, LLC 
DIVERSICARE LEASING COMPANY II, LLC 
DIVERSICARE PROPERTY CO., LLC

	By:
	/s/Kerry D. Massey

	Name:
	Kerry D. Massey

	Its:
	Executive Vice President and Chief Financial Officer

	
				
	SENIOR CARE CEDAR HILLS, LLC
SENIOR CARE GOLFCREST, LLC
SENIOR CARE GOLFVIEW, LLC
SENIOR CARE SOUTHERN PINES, LLC

	BY:
	SENIOR CARE FLORIDA LEASING, LLC, its sole member

	 
	BY:
	DIVERSICARE LEASING CORP., its sole member

	 
	By:
	/s/Kerry D. Massey

	 
	Name:
	Kerry D. Massey

	 
	Its:
	Executive Vice President and Chief Financial Officer

	
				
	SENIOR CARE FLORIDA LEASING, LLC
DIVERSICARE AFTON OAKS, LLC
DIVERSICARE BRIARCLIFF, LLC
DIVERSICARE CHISOLM, LLC
DIVERSICARE HARTFORD, LLC
DIVERSICARE PINEDALE, LLC
DIVERSICARE WINDSOR HOUSE, LLC
DIVERSICARE ROSE TERRACE, LLC
DIVERSICARE THERAPY SERVICES, LLC
DIVERSICARE CLINTON, LLC 
DIVERSICARE HIGHLANDS, LLC

	BY:
	DIVERSICARE LEASING CORP., its sole member

	 
	By:
	/s/Kerry D. Massey

	 
	Name:
	Kerry D. Massey

	 
	Its:
	Executive Vice President and Chief Financial Officer

	 

	
				
	DIVERSICARE BALLINGER, LLC
DIVERSICARE DOCTORS, LLC
DIVERSICARE ESTATES, LLC
DIVERSICARE KATY, LLC
DIVERSICARE NORMANDY TERRACE, LLC 
DIVERSICARE TREEMONT, LLC
DIVERSICARE PARIS, LLC 

	BY:
	DIVERSICARE TEXAS I, LLC, its sole member

	 
	By:
	/s/Kerry D. Massey

	 
	Name:
	Kerry D. Massey

	 
	Its:
	Executive Vice President and Chief Financial Officer

	
				
	DIVERSICARE OF CHANUTE, LLC
DIVERSICARE OF COUNCIL GROVE, LLC
DIVERSICARE OF HAYSVILLE, LLC
DIVERSICARE OF SEDGWICK, LLC 
DIVERSICARE OF HUTCHINSON, LLC
DIVERSICARE OF LARNED, LLC

	BY:
	DIVERSICARE KANSAS, LLC
its sole member

	 
	 

	 
	By:
	/s/Kerry D. Massey

	 
	Name:
	Kerry D. Massey

	 
	Its:
	Executive Vice President and Chief Financial Officer

DIVERSICARE OF SENECA PLACE, LLC
DIVERSICARE OF BRADFORD PLACE, LLC
DIVERSICARE OF PROVIDENCE, LLC
DIVERSICARE OF SIENA WOODS, LLC
DIVERSICARE OF ST. THERESA, LLC
DIVERSICARE OF BIG SPRINGS, LLC
DIVERSICARE OF NICHOLASVILLE, LLC
DIVERSICARE OF AVON, LLC
DIVERSICARE OF RIVERSIDE, LLC
DIVERSICARE OF CHATEAU, LLC
DIVERSICARE OF ST. JOSEPH, LLC 
DIVERSICARE OF GREENVILLE, LLC 

		
	By:
	DIVERSICARE LEASING COMPANY II, LLC, its sole member

By:  /s/Kerry D. Massey                 
	
		
	Name:
	Kerry D. Massey

	Its:
	Executive Vice President and Chief Financial Officer

DIVERSICARE AFTON OAKS PROPERTY, LLC
DIVERSICARE BRIARCLIFF PROPERTY, LLC
DIVERSICARE CHANUTE PROPERTY, LLC
DIVERSICARE CHISOLM PROPERTY, LLC
DIVERSICARE COUNCIL GROVE PROPERTY, LLC
DIVERSICARE HAYSVILLE PROPERTY, LLC
DIVERSICARE HARTFORD PROPERTY, LLC
DIVERSICARE HILLCREST PROPERTY, LLC
DIVERSICARE HUTCHINSON PROPERTY, LLC
DIVERSICARE LAMPASAS PROPERTY, LLC
DIVERSICARE LARNED PROPERTY, LLC
DIVERSICARE SEDGWICK PROPERTY, LLC
DIVERSICARE WINDSOR HOUSE PROPERTY, LLC
DIVERSICARE YORKTOWN PROPERTY, LLC
DIVERSICARE GLASGOW PROPERTY, LLC
DIVERSICARE CLINTON PROPERTY, LLC
DIVERSICARE FULTON PROPERTY, LLC 
DIVERSICARE SELMA PROPERTY, LLC

		
	By:
	DIVERSICARE PROPERTY CO., LLC, its sole member

By:  /s/Kerry D. Massey                 
Name: Kerry D. Massey
		
	Its:
	Executive Vice President and Chief Financial Officer

DIVERSICARE OF GLASGOW, LLC
DIVERSICARE OF FULTON, LLC 
DIVERSICARE OF SELMA, LLC

		
	By:
	DIVERSICARE HOLDING COMPANY, LLC, its sole member

By:  /s/Kerry D. Massey                 
Name: Kerry D. Massey
		
	Its:
	Executive Vice President and Chief Financial Officer

DIVERSICARE LEASING COMPANY III, LLC

By:    /s/Kerry D. Massey                 
	
		
	Name:
	Kerry D. Massey

	Its:
	Executive Vice President and Chief Financial Officer

DIVERSICARE OF ARAB, LLC
DIVERSICARE OF BOAZ, LLC
DIVERSICARE OF FOLEY, LLC
DIVERSICARE OF HUEYTOWN, LLC
DIVERSICARE OF LANETT, LLC
DIVERSICARE OF BESSEMER, LLC
DIVERSICARE OF MONTGOMERY, LLC
DIVERSICARE OF ONEONTA, LLC
DIVERSICARE OF OXFORD, LLC
DIVERSICARE OF PELL CITY, LLC
DIVERSICARE OF RIVERCHASE, LLC
DIVERSICARE OF WINFIELD, LLC
DIVERSICARE OF AMORY, LLC
DIVERSICARE OF BATESVILLE, LLC
DIVERSICARE OF BROOKHAVEN, LLC
DIVERSICARE OF CARTHAGE, LLC
DIVERSICARE OF EUPORA, LLC
DIVERSICARE OF MERIDIAN, LLC
DIVERSICARE OF RIPLEY, LLC
DIVERSICARE OF SOUTHAVEN, LLC
DIVERSICARE OF TUPELO, LLC
DIVERSICARE OF TYLERTOWN, LLC 

		
	By:
	DIVERSICARE LEASING COMPANY III, LLC, its sole member

By:  /s/Kerry D. Massey                 
Name: Kerry D. Massey
		
	Its:
	Executive Vice President and Chief Financial Officer

RELEASED BORROWER:

DIVERSICARE HILLCREST, LLC
DIVERSICARE LAMPASAS, LLC
DIVERSICARE YORKTOWN, LLC

		
	By:
	DIVERSICARE LEASING CORP., its sole member

By:  /s/Kerry D. Massey                 
Name: Kerry D. Massey
		
	Its:
	Executive Vice President and Chief Financial Officer

DIVERSICARE HUMBLE, LLC

By: DIVERSICARE TEXAS I, LLC, its sole member

By:  /s/Kerry D. Massey                 
Name: Kerry D. Massey
		
	Its:
	Executive Vice President and Chief Financial Officer

	
			
	Acknowledged and Agreed:
DIVERSICARE HEALTHCARE SERVICES, INC.  
 
 
By: /s/James R. McKnight, Jr.           
Name:  James R. McKnight, Jr. 
Its:   President and Chief Executive Officer

	 
	 
	 

ADMINISTRATIVE AGENT:

CIBC BANK USA, formerly known as The PrivateBank and Trust Company, in its capacity as administrative agent

By: /s/Adam D. Panos                
Name:  Adam D. Panos
Its:  Managing Director

LENDER:

CIBC BANK USA, formerly known as The PrivateBank and Trust Company

By: /s/Adam D. Panos                
Name:  Adam D. Panos
Its:  Managing Director

	
			
	LENDER:
BANKERS TRUST COMPANY 

	By: /s/Jon M. Doll_______________________
	 

	Name:
	Jon M. Doll
	 

	Its:
	Vice President
	 

	
			
	LENDER:
BOKF, NA D/B/A BANK OF OKLAHOMA 

	By: /s/Ky Chaffin_______________________
	 

	Name:
	Ky Chaffin
	 

	Its:
	Senior Vice President
	 

	
			
	LENDER:
CIT BANK, N.A. 

	By: /s/Richard Reynoso___________________
	 

	Name:
	Richard Reynoso
	 

	Its:
	Vice President
	 

	
			
	LENDER:
OPUS BANK,  
a California commercial bank 

	By: /s/Sangjin Na            
	 

	Name:
	Sangjin Na
	 

	Its:
	Vice President
	 

	
			
	LENDER:
FRANKLIN SYNERGY BANK 

	By: /s/Lisa Fletcher            
	 

	Name:
	Lisa Fletcher
	 

	Its:
	Senior Vice President
	 

ANNEX A 
(LENDERS, PRO RATA SHARES/DOLLAR ALLOCATIONS, AND NOTICE INFORMATION)

	
			
	Lender
	Contact Information
	

Pro Rata Shares

	 
	 
	 

	CIBC Bank USA
	120 South LaSalle Street
Chicago, IL  60603
Attn.:  Adam D. Panos
Managing Director
Tel.:  (312) 564-1278
Fax: 312-800-9733

Dollar Allocation:
$14,828,947.36 

	36.84210527%

	CIT Bank, N.A.
	

11 West 42nd Street
New York, NY  10036
Attn.:  Edward Shuster
Director
Tel.:  (212) 771-9303

Dollar Allocation:
$8,473,684.21 

	21.05263158%

	Bankers Trust Company
	453 7th Street
Des Moines, IA  50304-0897
Attn.:  Jon M. Doll
Vice President
Tel.:  (515) 245-2837
Fax:  (515) 245-5216

Dollar Allocation:
$6,355,263.16

	15.78947368%

	BOKF, NA d/b/a Bank of Oklahoma
	

One Williams Center, Suite 8NE
Tulsa, OK  74172
Attn.:  Ky Chaffin
Senior Vice President
Tel.: (918) 588-6866
Fax: (918) 280-3368

Dollar Allocation:
$2,118,421.05 

	5.26315789%

	Opus Bank
	

2101 Rosecrans Ave.
Suite 4300
El Segundo, CA 90245
Attn.:  Sangjin Na, VP, Portfolio Manager, Healthcare Banking
Tel.:  (310) 481-6214
Fax:  (949) 250-9988, Attn: Kathy Brennan

Dollar Allocation:
$4,236,842.11 

	10.52631579%

	Franklin Synergy Bank
	

722 Columbia Ave.
Franklin, TN 37064
Chicago, IL  60606
Attn.:  Lisa Fletcher
Senior Vice President
Tel.:  (615) 564-6374
Fax:  (312) 564-7375

Dollar Allocation:
$4,236,842.11
	10.52631579%

REAFFIRMATION OF SECOND AMENDED AND RESTATED GUARANTY

Dated as of May 13, 2019
The undersigned (“Guarantor”) hereby: (i) confirms and agrees with CIBC BANK USA, formerly known as CIBC BANK USA, formerly known as The PrivateBank and Trust Company, an Illinois banking corporation, in its capacity as administrative agent (together with its successors and assigns, “Administrative Agent”) that Guarantor’s Second Amended and Restated Guaranty dated as of February 26, 2016 made in favor of Administrative Agent (as amended or modified, “Guaranty”), remains in full force and effect and is hereby ratified and confirmed in all respects, including with regard to the Third Amended and Restated Revolving Loan and Security Agreement dated as of February 26, 2016, as amended prior to the date hereof and as further amended by the foregoing Seventh Amendment to Third Amended and Restated Revolving Loan and Security Agreement and Omnibus Release (“Amendment”), and each reference to the “Loan Agreement” shall refer to the Loan Agreement as amended by the Amendment; (ii) represents and warrants to Administrative Agent, which representations and warranties shall survive the execution and delivery hereof, that Guarantor’s representations and warranties contained in the Guaranty are true and correct as of the date hereof, with the same effect as though made on the date hereof, except to the extent that such representations expressly related solely to an earlier date, in which case such representations were true and correct on and as of such earlier date (and except for the representations in Section 10(b) thereof which were true and correct on and as of the date when made); (iii) agrees and acknowledges that such ratification and confirmation is not a condition to the continued effectiveness of the Amendment or the Guaranty; and (iv) agrees that neither such ratification and confirmation, nor Administrative Agent’s solicitation of such ratification and confirmation, constitutes a course of dealing giving rise to any obligation or condition requiring a similar or any other ratification or confirmation from the undersigned with respect to subsequent amendments or modifications, if any, to the Loan Agreement, as amended by the Amendment or any other Financing Agreement (as defined in the Loan Agreement, as amended by the Amendment).  The execution, delivery and effectiveness of this instrument shall not operate as a waiver of any right, power or remedy of Administrative Agent under or pursuant to the Guaranty.  Guarantor acknowledges and agrees that Guarantor has received and reviewed a fully-executed copy of the Amendment (and any other instrument, document or agreement executed or delivered in connection therewith) and understands the contents thereof.  A signature hereto sent or delivered by facsimile or other electronic transmission shall be as legally binding and enforceable as a signed original for all purposes.  This instrument shall be governed by and construed and enforced in accordance with the internal laws of the State of Illinois, without regard to conflict of law principles that would require the application of any other laws.
[Signature Page Follows]

DIVERSICARE HEALTHCARE SERVICES, INC. 

By:/s/James R. McKnight, Jr.            
Name: James R. McKnight, Jr.
Its:    President and Chief Executive     Officer

REAFFIRMATION OF PLEDGE AGREEMENTS

Dated as of May 13, 2019
For good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, the undersigned, respectively and as applicable hereby (a) confirms and agrees with CIBC BANK USA, formerly known as The PrivateBank and Trust Company, an Illinois banking corporation, in its capacity as administrative agent (together with its successors and assigns, “Administrative Agent”), that (i) Second Amended and Restated Pledge Agreement by and between Diversicare Management Services Co. and Administrative Agent dated as of February 26, 2016, (ii) Second Amended and Restated Pledge Agreement by and between Advocat Finance, Inc. and Administrative Agent dated as of February 26, 2016, (iii) Second Amended and Restated Pledge Agreement by and between Diversicare Leasing Corp. and Administrative Agent dated as of February 26, 2016, (iv) Second Amended and Restated Pledge Agreement by and between Senior Care Florida Leasing Corp. and Administrative Agent dated as of February 26, 2016, (v) Amended and Restated Pledge Agreement by and between Diversicare Leasing Company II, LLC and Administrative Agent dated as of February 26, 2016, (vi) Amended and Restated Pledge Agreement by and between Diversicare Kansas, LLC and Administrative Agent dated as of February 26, 2016, (vii) Second Amended and Restated Pledge Agreement by and between Diversicare Healthcare Services, Inc. (f/k/a Advocat Inc.) and Administrative Agent dated as of February 26, 2016, (viii) Pledge Agreement by and between Diversicare Leasing Company III, LLC and Administrative Agent dated as of October 1, 2016 and effective as of October 3, 2016, (ix) Amended and Restated Pledge Agreement by and between Diversicare Property Co., LLC and Administrative Agent dated as of February 26, 2016 and (x) Amended and Restated Pledge Agreement by and between Diversicare Holding Company, LLC and Administrative Agent dated as of February 26, 2016 (the foregoing, as the same may be amended, restated, supplemented or otherwise modified from time to time, individually, “Pledge Agreement” and, collectively, “Pledge Agreements”), each remains in full force and effect and is hereby ratified and confirmed in all respects, including with regard to the Third Amended and Restated Revolving Loan and Security Agreement dated as of February 26, 2016 by and among Diversicare Management Services Co., a Tennessee corporation, and those certain affiliates of Diversicare Management Services Co. that are signatories thereto as borrowers, Administrative Agent and the Lenders, as the same has been amended prior to the date hereof and as amended by the foregoing Seventh Amendment to Third Amended and Restated Revolving Loan and Security Agreement and Omnibus Release dated of even date herewith (“Amendment”), and each reference to the “Loan Agreement” shall refer to the Loan Agreement as amended by the Amendment, and all of the undersigned’s respective liabilities and obligations under and pursuant to the respective Pledge Agreement, as modified by the Amendment (if and as applicable), are and shall be valid and enforceable and shall not be impaired or limited in any way by the execution, delivery or effectiveness of the Amendment; (b) represents and warrants to Administrative Agent and Lenders, which representations and warranties shall survive the execution and delivery hereof, that each of the undersigned’s representations and warranties contained in the Pledge Agreement are true and correct as of the date hereof, with the same effect as though made on the date hereof, except to the extent that such representations expressly related solely to an earlier date, in which case such representations were true and correct on and as of such earlier date, each of the undersigned has the full right, authority and power to enter into this Reaffirmation and this Reaffirmation constitutes the legal, valid and binding obligation of each of the undersigned, enforceable against each of the undersigned in accordance with its terms, subject to the effect of any applicable bankruptcy, insolvency, reorganization or similar law affecting creditor’s rights generally and general principles of equity; (c) agrees and acknowledges that such ratification and confirmation is not a condition to the continued effectiveness of the Amendment or the Pledge Agreement; and (d) agrees that neither such ratification and confirmation, nor the solicitation of such ratification and confirmation by Administrative Agent and Lenders, constitutes a course of dealing giving rise to any obligation or condition requiring a similar or any other ratification or confirmation from the undersigned with respect to subsequent amendments or modifications, if any, to the Loan Agreement, as amended by the Amendment or any other Financing Agreement (as defined in the Loan Agreement).  The execution, delivery and effectiveness of this instrument shall not operate as a waiver of any right, power or remedy of Administrative Agent or Lenders under the Pledge Agreements.  Each of the undersigned acknowledges and agrees that it has received and reviewed a fully-executed copy of the Amendment and understands the contents thereof.  A signature hereto sent or delivered by facsimile or other electronic transmission shall be as legally binding and enforceable as a signed original for all purposes.  Illinois law shall govern the construction, interpretation and enforcement of this instrument.
[Signature Page Follows]

IN WITNESS WHEREOF, each of the undersigned has duly executed this Reaffirmation of Pledge Agreements on and as of the date above.
DIVERSICARE MANAGEMENT SERVICES CO., a Tennessee corporation

By: /s/Kerry D. Massey            
Name: Kerry D. Massey
		
	Its:
	Executive Vice President and Chief Financial Officer

 

ADVOCAT FINANCE INC., a Delaware corporation

By: /s/Kerry D. Massey            
Name: Kerry D. Massey
		
	Its:
	Executive Vice President and Chief Financial Officer

 

DIVERSICARE LEASING CORP.,  
a Tennessee corporation

By: /s/Kerry D. Massey            
Name: Kerry D. Massey
		
	Its:
	Executive Vice President and Chief Financial Officer

SENIOR CARE FLORIDA LEASING, LLC, a Delaware limited liability company

By:  Diversicare Leasing Corp., its sole member

By: /s/Kerry D. Massey            
Name: Kerry D. Massey
		
	Its:
	Executive Vice President and Chief Financial Officer

DIVERSICARE LEASING COMPANY II, LLC, a Delaware limited liability company

By: /s/Kerry D. Massey            
Name: Kerry D. Massey
		
	Its:
	Executive Vice President and Chief Financial Officer

DIVERSICARE KANSAS, LLC, a Delaware limited liability company
 
By:    DIVERSICARE HOLDING COMPANY, LLC, its sole member
 

By: /s/Kerry D. Massey            
Name: Kerry D. Massey
		
	Its:
	Executive Vice President and Chief Financial Officer

DIVERSICARE LEASING COMPANY III, LLC,  
a Delaware limited liability company

By: /s/Kerry D. Massey            
Name: Kerry D. Massey
		
	Its:
	Executive Vice President and Chief Financial Officer

DIVERSICARE HEALTHCARE SERVICES, INC., a Delaware corporation 
 
 

By: /s/James R. McKnight, Jr._____________
Name: James R. McKnight, Jr.
		
	Its:
	President and Chief Executive Officer

 

DIVERSICARE PROPERTY CO., LLC,  
a Delaware limited liability company 
 

By: /s/Kerry D. Massey            
Name: Kerry D. Massey
		
	Its:
	Executive Vice President and Chief Financial Officer

DIVERSICARE HOLDING COMPANY, LLC, a Delaware limited liability company
  
By: /s/Kerry D. Massey            
Name: Kerry D. Massey
		
	Its:
	Executive Vice President and Chief Financial Officer

DM3\5663979.5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]